# Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer

> **NCT01706458** · PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 18 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **BIOLOGICAL:** sipuleucel-T
- **BIOLOGICAL:** DNA Vaccine

## Key facts

- **NCT ID:** NCT01706458
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-20
- **Primary completion:** 2017-06-12
- **Final completion:** 2020-08-13
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2021-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01706458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01706458, "Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01706458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*